Zentalis Executive Sells 39,224 Shares in February; Analyst Lowers Price Target After Pipeline Update
Vincent Vultaggio, principal accounting officer and principal financial officer at Zentalis Pharmaceuticals (ZNTL), sold 39,224 shares of the company’s common stock across three trades between February 6 and February 10, 2026, generating $97,556. The early-February sales included automated transactions to cover tax obligations tied to vested restri…